• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未选择的终末期患者临床实验室指标的非特异性变化,以及基于前瞻性观察研究的预测生存时间的模型。

Nonspecific changes in clinical laboratory indicators in unselected terminally ill patients and a model to predict survival time based on a prospective observational study.

机构信息

College of Medical Laboratory, Dalian Medical University, Dalian 116044, China.

出版信息

J Transl Med. 2014 Mar 22;12:78. doi: 10.1186/1479-5876-12-78.

DOI:10.1186/1479-5876-12-78
PMID:24655421
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3994344/
Abstract

BACKGROUND

The clinical prediction of survival is among the most challenging tasks because it refers to the process whereby the medical team assimilates clinical data using subjective methods. The purpose of this prospective observational study was to develop a model for evaluating survival time using objective laboratory parameters.

METHODS

Albumin (ALB), creatinine (CRE), C-reactive protein (CRP) and the neutrophilic leukocyte count (NEU) were measured using automated analysers. A total of 177 subjects with any one positive item of 4 items were included in the study. Age on the observation date and date of death were recorded.

RESULTS

ALB, CRE, CRP and the NEU were all significant predictors of survival time (p < 0.05). The median survival time of patients with anyone of the 4 items positive would be over 1 year; if any 2 items were positive, the median survival time was approximately 1 year; if any 3 items were positive, the median survival time was approximately 4 months and if 4 items were positive, the median survival time was approximately 20 days.

CONCLUSIONS

This study suggests that a model using ALB, CRE, CRP and the NEU is potentially useful in the objective evaluation of survival time in terminally ill patients.

摘要

背景

临床预测生存是最具挑战性的任务之一,因为它涉及到医疗团队使用主观方法综合临床数据的过程。本前瞻性观察研究的目的是开发一种使用客观实验室参数评估生存时间的模型。

方法

使用自动分析仪测量白蛋白(ALB)、肌酐(CRE)、C 反应蛋白(CRP)和中性粒细胞计数(NEU)。共纳入 177 例 4 项中有任何一项阳性的患者。记录观察日期的年龄和死亡日期。

结果

ALB、CRE、CRP 和 NEU 均是生存时间的显著预测因子(p < 0.05)。任何 4 项中有 1 项阳性的患者中位生存时间超过 1 年;如果有 2 项阳性,中位生存时间约为 1 年;如果有 3 项阳性,中位生存时间约为 4 个月;如果 4 项均阳性,中位生存时间约为 20 天。

结论

本研究表明,使用 ALB、CRE、CRP 和 NEU 的模型可能有助于客观评估终末期患者的生存时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc9c/3994344/0d9ea1c13c11/1479-5876-12-78-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc9c/3994344/0d9ea1c13c11/1479-5876-12-78-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc9c/3994344/0d9ea1c13c11/1479-5876-12-78-1.jpg

相似文献

1
Nonspecific changes in clinical laboratory indicators in unselected terminally ill patients and a model to predict survival time based on a prospective observational study.未选择的终末期患者临床实验室指标的非特异性变化,以及基于前瞻性观察研究的预测生存时间的模型。
J Transl Med. 2014 Mar 22;12:78. doi: 10.1186/1479-5876-12-78.
2
A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients.一项关于C反应蛋白作为晚期癌症患者生存时间预后因素的前瞻性研究。
Support Care Cancer. 2007 Jun;15(6):613. doi: 10.1007/s00520-006-0208-5. Epub 2007 Jan 18.
3
The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer.EORTC QLQ-C15-PAL 评分和炎症生物标志物在预测癌症终末期患者生存中的作用。
BMC Cancer. 2021 Mar 23;21(1):304. doi: 10.1186/s12885-021-08049-3.
4
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.术前C反应蛋白/白蛋白比值在卵巢癌中的预后价值
BMC Cancer. 2017 Apr 21;17(1):285. doi: 10.1186/s12885-017-3220-x.
5
Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.术前C反应蛋白与白蛋白比值在结直肠癌患者中的预后意义
Anticancer Res. 2016 Mar;36(3):995-1001.
6
Associations among albuminuria, C-reactive protein concentrations, survival predictor index scores, and survival in 78 critically ill dogs.78 例危重病犬白蛋白尿、C 反应蛋白浓度、生存预测指数评分与生存的相关性。
J Vet Intern Med. 2011 Jul-Aug;25(4):818-24. doi: 10.1111/j.1939-1676.2011.0731.x. Epub 2011 May 12.
7
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.一种基于炎症的新型食管癌预后评分:C反应蛋白/白蛋白比值
BMC Cancer. 2015 May 2;15:350. doi: 10.1186/s12885-015-1379-6.
8
The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients.C 反应蛋白/白蛋白比值可用于预测癌症和非癌症患者的短期生存。
J Palliat Med. 2019 May;22(5):532-537. doi: 10.1089/jpm.2018.0404. Epub 2018 Dec 20.
9
Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.晚期结直肠癌患者营养与炎症状态评估及其与生存的相关性
Nutr Cancer. 2006;55(1):78-85. doi: 10.1207/s15327914nc5501_10.
10
Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study.为晚期癌症患者构建新的客观预后评分:一项多中心研究。
Support Care Cancer. 2010 Feb;18(2):151-7. doi: 10.1007/s00520-009-0639-x. Epub 2009 Apr 21.

引用本文的文献

1
A new pathway for considering trigger factors based on parallel-serial connection models and displaying the relationships of causal factors in low-probability events.基于并串联连接模型考虑触发因素的新途径,并显示低概率事件中因果因素的关系。
BMC Med Res Methodol. 2023 Apr 15;23(1):93. doi: 10.1186/s12874-023-01919-3.
2
Need for discriminating between diagnostic and screening efficacy to estimate a biomarker based on case control and cohort studies.需要区分基于病例对照和队列研究的诊断和筛查功效来评估生物标志物。
Sci Rep. 2021 Nov 17;11(1):22450. doi: 10.1038/s41598-021-01904-0.
3
A grading system from health to death using routine experimental indicators based on the pre-chronic disease status theory.

本文引用的文献

1
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons.基于核磁共振波谱的生物标志物分析预测全因死亡率:对 17345 人的观察性研究。
PLoS Med. 2014 Feb 25;11(2):e1001606. doi: 10.1371/journal.pmed.1001606. eCollection 2014 Feb.
2
Objective assessment of stress levels and health status using routinely measured clinical laboratory parameters as biomarkers.使用常规测量的临床实验室参数作为生物标志物来客观评估压力水平和健康状况。
Biomarkers. 2011 Sep;16(6):525-9. doi: 10.3109/1354750X.2011.606505. Epub 2011 Aug 19.
3
Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care.
基于预慢病状态理论,使用常规实验指标对健康至死亡进行分级系统。
BMC Geriatr. 2020 Jul 20;20(1):250. doi: 10.1186/s12877-020-01653-1.
4
Analyzing the Relationship between Cohort and Case-Control Study Results Based on Model for Multiple Pathogenic Factors.基于多病因模型分析队列研究和病例对照研究结果的关系
Comput Math Methods Med. 2019 Dec 30;2019:7507043. doi: 10.1155/2019/7507043. eCollection 2019.
比较 Charlson 合并症指数与 SAPS 和 APACHE 评分对 ICU 后死亡率的预测
Clin Epidemiol. 2011;3:203-11. doi: 10.2147/CLEP.S20247. Epub 2011 Jun 17.
4
Performance of the third-generation models of severity scoring systems (APACHE IV, SAPS 3 and MPM-III) in acute kidney injury critically ill patients.第三代严重程度评分系统(APACHE IV、SAPS 3 和 MPM-III)在急性肾损伤危重症患者中的表现。
Nephrol Dial Transplant. 2011 Dec;26(12):3894-901. doi: 10.1093/ndt/gfr201. Epub 2011 Apr 19.
5
Serum creatinine improves body mass index survival prediction in hemodialysis patients: a 1-year prospective cohort analysis from the ARNOS study.血清肌酐可改善血液透析患者的体重指数生存预测:来自 ARNOS 研究的 1 年前瞻性队列分析。
J Ren Nutr. 2011 Sep;21(5):369-75. doi: 10.1053/j.jrn.2010.08.005. Epub 2011 Jan 15.
6
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.提高 C-反应蛋白在肾细胞癌术前生存预测中的准确性。
Br J Cancer. 2010 Nov 23;103(11):1649-56. doi: 10.1038/sj.bjc.6605973. Epub 2010 Nov 9.
7
The value of procalcitonin and the SAPS II and APACHE III scores in the differentiation of infectious and non-infectious fever in the ICU: a prospective, cohort study.降钙素原、SAPS II 和 APACHE III 评分在 ICU 中鉴别感染性和非感染性发热的价值:一项前瞻性队列研究。
J Korean Med Sci. 2010 Nov;25(11):1633-7. doi: 10.3346/jkms.2010.25.11.1633. Epub 2010 Oct 26.
8
Risk-adjusted scoring systems in colorectal surgery.结直肠外科手术中的风险调整评分系统。
Int J Surg. 2011;9(2):130-5. doi: 10.1016/j.ijsu.2010.10.016. Epub 2010 Nov 5.
9
Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.MELD 评分在预测失代偿性肝硬化患者因静脉曲张出血、肝肾综合征、酒精性肝炎或急性肝衰竭导致的死亡率以及非移植手术或 TIPS 后死亡率方面的准确性。
Dig Dis Sci. 2011 Apr;56(4):977-87. doi: 10.1007/s10620-010-1390-3. Epub 2010 Sep 16.
10
Serum glucose- and C-reactive protein-based assessment of stress status in a healthy population.基于血清葡萄糖和C反应蛋白对健康人群应激状态的评估。
Clin Lab. 2010;56(5-6):227-30.